AstraZeneca Plc plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other European drugmakers ...

AstraZeneca Plc plans to invest US$50bil in the United States before 2030, becoming the latest European pharma company to ...

MUNICH/WASHINGTON] AstraZeneca plans to invest US$50 billion in the US before 2030, becoming the latest European pharma company to ratchet up spending in the country ahead of potential tariffs on ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

Astra, led by boss Pascal Soriot (pictured), said it is accelerating its expansion in US with an investment that will create ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca PLC plans to invest $50 billion in the US before 2030, becoming the latest European pharma company to ratchet up ...

The move is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry. Read more at ...

In 2023, AstraZeneca said it had decided not to build a new $400m drug factory in Britain because of its “discouraging” tax ...

AstraZeneca (AZN) said it is investing $50 billion in US manufacturing by 2030, following the lead of big pharma peers that ...

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...